E Fund Management Co., Ltd. 2seventy Bio, Inc. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$8.45 - $12.48 $1,529 - $2,258	-181 Reduced 1.44%	12,420 $126,000
Q1 2023 May 11, 2023	BUY	$9.21 - $14.98 $116,055 - $188,762	12,601 New	12,601 $129,000
Q2 2022 Aug 15, 2022	SELL	$10.55 - $18.81 $116,419 - $207,568	-11,035 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$11.67 - $26.72 $128,778 - $294,855	11,035 New	11,035 $188,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $137M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.